Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation
- PMID: 32459417
- PMCID: PMC7263355
- DOI: 10.1097/AOG.0000000000003864
Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation
Erratum in
-
Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation: Correction.Obstet Gynecol. 2020 Sep;136(3):638. doi: 10.1097/AOG.0000000000004064. Obstet Gynecol. 2020. PMID: 32826590 No abstract available.
Abstract
Background: Women with germline BRCA1 or BRCA2 mutations have a lifetime risk of ovarian cancer of up to 46%. Opportunistic salpingectomy has been advocated as a risk-reducing strategy owing to increasing recognition of tubal origin, yet evidence of efficacy in this high-risk population is limited.
Case: This is the case of a woman with a BRCA1 mutation who underwent prophylactic mastectomy and bilateral salpingectomy with ovarian retention before the age of 40 years. She did not undergo oophorectomy and subsequently developed stage IV high-grade serous ovarian cancer 4 years after her initial surgery.
Conclusion: More research is needed to determine the role of prophylactic salpingectomy with delayed oophorectomy, optimal timing of completion oophorectomy, and the risks and benefits compared with up-front risk-reducing salpingo-oophorectomy.
Conflict of interest statement
Financial Disclosure:
Outside the submitted work, Dr. Chi reports personal fees from Bovie Medical Co. (Medical Advisory Board and stock options), Apyx Medical Corp. (Medical Advisory Board and stock options), C Surgeries (shareholder), and Biom ‘Up, (Medical Advisory Board). The other authors did not report any potential conflicts of interest.
Figures
Comment in
-
Too Good to Be True.Obstet Gynecol. 2020 Jun;135(6):1267-1269. doi: 10.1097/AOG.0000000000003916. Obstet Gynecol. 2020. PMID: 32459416 No abstract available.
References
-
- Siegel RL, Miller KD and Jemal A (2019), Cancer statistics, 2019. CA A Cancer J Clin, 69: 7–34. - PubMed
-
- Lancaster JM, Powell CB, Chen LM, Richardson DL, Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions Gynecologic Oncology, Volume 136, Issue 1, 3–7, 2015 - PubMed
-
- Society of Gynecologic Oncology Clinical Practice Statement: Salpingectomy for Ovarian Cancer Prevention, November 2013.
-
- Powell CB. Risk-reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later. Gynecol Oncol. 2014; 132 (2): 261–263. - PubMed
-
- Kwon JS, Tinker A, Pansegrau G, McAlpine J, Housty M, McCullum M et al. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers. Obstet Gynecol. 2013; 121 (1):14–24. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
